Stock LGND LIGAND PHARMACEUTICALS INCORPORATED
Add to a list
To use this feature you must be a member
Log inSign up

Revisions Ligand Pharmaceuticals Incorporated

Equities

LGND

US53220K5048

Market Closed - Nasdaq
Other stock markets
 16:00:00 2024-04-29 EDT 		5-day change 1st Jan Change
70.46 USD -0.16% Intraday chart for Ligand Pharmaceuticals Incorporated +2.82% -1.34%
04-08 Ligand Pharmaceuticals Incorporated Announces New Topiram Injection Data Presented At 9th London-Innsbruck Colloquium on Status Epilepticus and Acute Seizures Conference CI
04-03 Ligand Pharmaceuticals Appoints Scott Plesha to the Role of Chief Executive Officer CI

Turnover - Change in analysts' estimates

Earnings Per Share (EPS) - Change in analysts' estimates

EBIT - Change in analysts' estimates

Turnover

Earnings Per Share (EPS)

EBIT

  1. Stock Market
  2. Equities
  3. LGND Stock
  4. Revisions Ligand Pharmaceuticals Incorporated